Announcing the 2022 #KidneyWk NephJC Graphic
Diuretic Resistance: the Visual Abstract
This one is a difficult one. And Sophia Ambruso had created a nice one for NephMadness - so why mess with such a nice piece of work? Here it is:
This week, we will discuss whether less is more when it comes to discontinuing dialysis in patients with AKI and a chance to recover.
Holy Mackerel! This week we will discuss fish oil use in maintenance hemodialysis patients. Could this be the one thing that bends the curve on CV mortality, or is it just a red herring?
This week, we will discuss the phase 3 ORIGIN3 trial of atacicept, an APRIL/BAFF inhibitor for use in IgAN.
Day 3 of Kidney Week. Sibeprenlimab and Balcinrenone on NEJM and Lancet, plus a couple of other non-kidneywk studies.
This one is a difficult one. And Sophia Ambruso had created a nice one for NephMadness - so why mess with such a nice piece of work? Here it is: